Pile-on over PBMs continues with FTC comments and a new bipartisan Senate bill - Endpoints News

More than 500 stakeholders sent comments to the FTC on whether the commission should look further into pharma middlemen, known as PBMs, with many of the commenters calling for more federal oversight. Similar to the critical open comment period in a deadlocked…

More than 500 stake­hold­ers sent com­ments to the FTC on whether the com­mis­sion should look fur­ther in­to phar­ma mid­dle­men, known as PBMs, with many of the com­menters call­ing for more fed­er… [+3592 chars]

full article...